As of September 29, 2026, Rigel Pharmaceuticals's top three insider holders are Raul R Rodriguez (Ceo, President, 273.36K shares), Dean L Schorno (Evp Chief Financial Officer, 82.96K shares), David A Santos (Evp, Chief Commercial Officer, 61.62K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Raul R Rodriguez | Ceo, President | 273,362 | 0 | 273,362 | 44.2% | 03 Sep, 2026 |
| 2 | Dean L Schorno | Evp Chief Financial Officer | 82,962 | 0 | 82,962 | 13.4% | 03 Sep, 2026 |
| 3 | David A Santos | Evp, Chief Commercial Officer | 61,622 | 0 | 61,622 | 10.0% | 03 Sep, 2026 |
| 4 | Raymond J. Furey | Evp, Gc, Cco Corp Sec | 50,559 | 0 | 50,559 | 8.2% | 03 Sep, 2026 |
| 5 | Alison L. Hannah | Evp, Chief Medical Officer | 35,025 | 0 | 35,025 | 5.7% | 10 Jul, 2026 |
| 6 | Lisa Rojkjaer | Evp, Chief Medical Officer | 34,003 | 0 | 34,003 | 5.5% | 03 Jun, 2026 |
| 7 | Walter H Moos | Director | 18,472 | 0 | 18,472 | 3.0% | 19 May, 2026 |
| 8 | Jane Wasman | Director | 18,250 | 0 | 18,250 | 2.9% | 19 May, 2026 |
| 9 | Anthony Gregg Lapointe | Director | 18,250 | 0 | 18,250 | 2.9% | 19 May, 2026 |
| 10 | Kamil Ali-Jackson | Director | 10,125 | 0 | 10,125 | 1.6% | 24 Jun, 2026 |
| 11 | Mark W Frohlich | Director | 7,000 | 0 | 7,000 | 1.1% | 19 May, 2026 |
| 12 | Michael Patrick Miller | Director | 5,937 | 0 | 5,937 | 1.0% | 19 May, 2026 |
| 13 | Brian L. Kotzin | Director | 1,111 | 0 | 1,111 | 0.2% | 29 May, 2024 |
| 14 | Gary A Lyons | Director | 833 | 0 | 833 | 0.1% | 12 Jul, 2023 |
| 15 | Wolfgang Dummer | Evp Cmo | 805 | 0 | 805 | 0.1% | 06 Feb, 2023 |
| 16 | Dolly Vance | Evp Corp. Affairs, G.C., Sect. | 670 | 0 | 670 | 0.1% | 26 Jan, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Sep, 2026 | Raymond J. Furey | Evp, Gc, Cco Corp Sec | Disposed F | 877 | $47.50 | $41.66K | 50,559 | Direct |
| 01 Sep, 2026 | Raul R Rodriguez | Ceo, President | Disposed F | 2,424 | $47.50 | $115.14K | 273,362 | Direct |
| 01 Sep, 2026 | David A Santos | Evp, Chief Commercial Officer | Disposed F | 874 | $47.50 | $41.52K | 61,622 | Direct |
| 01 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Disposed F | 928 | $47.50 | $44.08K | 78,362 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Acquired M | 694 | $12.70 | $8.81K | 79,056 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Acquired M | 620 | $18.70 | $11.59K | 79,676 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Acquired M | 2,000 | $24.20 | $48.40K | 81,676 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Acquired M | 1,286 | $24.20 | $31.12K | 82,962 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Disposed M | 694 | $0.00 | $0 | 12,824 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Disposed M | 620 | $0.00 | $0 | 9,012 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Disposed M | 2,000 | $0.00 | $0 | 7,999 | Direct |
| 02 Sep, 2026 | Dean L Schorno | Evp Chief Financial Officer | Disposed M | 1,286 | $0.00 | $0 | 15,867 | Direct |
| 08 Jul, 2026 | Alison L. Hannah | Evp, Chief Medical Officer | Acquired A | 24,400 | $0.00 | $0 | 35,025 | Direct |
| 22 Jun, 2026 | Kamil Ali-Jackson | Director | Disposed S | 2,500 | $35.00 | $87.50K | 10,125 | Direct |
| 17 Jun, 2026 | Raul R Rodriguez | Ceo, President | Acquired A | 31,700 | $0.00 | $0 | 31,700 | Direct |
| 17 Jun, 2026 | Lisa Rojkjaer | Evp, Chief Medical Officer | Acquired A | 9,375 | $0.00 | $0 | 9,375 | Direct |
| 17 Jun, 2026 | Raymond J. Furey | Evp, Gc, Cco Corp Sec | Acquired A | 7,394 | $0.00 | $0 | 7,394 | Direct |
| 17 Jun, 2026 | David A Santos | Evp, Chief Commercial Officer | Acquired A | 7,394 | $0.00 | $0 | 7,394 | Direct |
| 17 Jun, 2026 | Dean L Schorno | Evp Chief Financial Officer | Acquired A | 7,394 | $0.00 | $0 | 7,394 | Direct |
| 17 Jun, 2026 | Lisa Rojkjaer | Evp, Chief Medical Officer | Acquired A | 7,394 | $0.00 | $0 | 7,394 | Direct |